Costs of Illness for Huntington's Disease: A Systematic Review

被引:1
|
作者
Patil, Divya [1 ]
Gorman, Emily F. [2 ]
Mattingly II, T. Joseph [3 ]
机构
[1] Univ Maryland, Sch Pharm, Baltimore, MD USA
[2] Univ Maryland, Hlth Sci & Human Serv Lib, Baltimore, MD USA
[3] Univ Utah, Coll Pharm, 30 South 2000 East, Salt Lake City, UT 84112 USA
关键词
DIRECT MEDICAL COSTS; HEALTH;
D O I
10.1007/s41669-024-00531-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
BackgroundHuntington's disease (HD) is associated with significant financial burden for patients and payers. The objective was to identify and quantify costs of HD by stage of disease progression.MethodsA systematic search of Medline, Embase, Scopus, and Cochrane Library was used to identify types of costs that are frequently reported for individuals diagnosed with HD and to quantify those costs across early, middle, and late stages of HD. Full-text, original research articles were included if they reported costs specific to HD burden. To standardize stage-level costs, Shoulson Fahn and Barthel Index scores were combined to estimate the cost for early, middle-, and late-stage HD.ResultsA total of 692 abstracts were identifie,d and following abstract screening, a total of 80 full-text articles were reviewed for inclusion. Only five studies were included for extraction and synthesis including three from the USA, one from the United Kingdom (UK), and one from Peru. Annual inpatient, outpatient, drug costs, and caregiving costs all increased substantially as disease progressed. Outpatient costs were approximately 2.5 times greater than inpatient costs for early and middle stages of HD. Among all the costs associated with HD, annual caregiver cost emerges as the most significant costs in the economic burden of HD, ranging from a minimum of $6041 for early stage to a maximum of $133,200 for late-stage HD. Significant variation was observed across studies, especially comparing costs observed in Peru with the USA and UK.ConclusionOutpatient costs exceed inpatient costs, especially in early and middle stages, underscoring the importance of outpatient care. All costs seem to rise rapidly, in a nonlinear fashion, as patients advance to later stages. While only two studies reported caregiver burden, these costs were significanly higher in the most severe stage, where patients were completely dependent on a caregiver. This review highlights the complexity of cost assessment in HD and underscores the need for consistent methods and further research to guide effective policy actions.
引用
收藏
页码:5 / 13
页数:9
相关论文
共 50 条
  • [21] A SYSTEMATIC REVIEW OF REHABILITATION FOR CORTICOBULBAR SYMPTOMS IN ADULTS WITH HUNTINGTON'S DISEASE
    Burnip, Emma
    Wallace, Emma
    Gozdzikowska, Kristin
    Huckabee, Maggie-Lee
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A88 - A88
  • [22] Systematic Review of Pharmacological Treatments for Depressive Symptoms in Huntington's Disease
    Moulton, Calum D.
    Hopkins, C. W. P.
    Bevan-Jones, W. Richard
    MOVEMENT DISORDERS, 2014, 29 (12) : 1556 - 1561
  • [23] A Systematic Review of Rehabilitation for Corticobulbar Symptoms in Adults with Huntington's Disease
    Burnip, Emma
    Wallace, Emma
    Gozdzikowska, Kristin
    Huckabee, Maggie-Lee
    JOURNAL OF HUNTINGTONS DISEASE, 2020, 9 (01) : 1 - 12
  • [24] Suicidal ideation and behavior in Huntington's disease: Systematic review and recommendations
    Kachiand, Zachary R.
    Cohen-Zimerman, Shira
    Bega, Danny
    Gordon, Barry
    Grafman, Jordan
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 250 : 319 - 329
  • [25] Huntington's disease: A review
    Kumar, Puneet
    Naidu, P. S.
    Padi, S. S. V.
    Kumar, Anil
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2007, 41 (04) : 287 - 294
  • [26] A Review on Huntington's Disease
    Kumar, Avnesh
    Garg, Vipin Kumar
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 13 (01):
  • [27] Costs of Illness of Spinal Muscular Atrophy: A Systematic Review
    Erik Landfeldt
    Astrid Pechmann
    Hugh J. McMillan
    Hanns Lochmüller
    Thomas Sejersen
    Applied Health Economics and Health Policy, 2021, 19 : 501 - 520
  • [28] Costs of Illness of Spinal Muscular Atrophy: A Systematic Review
    Landfeldt, Erik
    Pechmann, Astrid
    McMillan, Hugh J.
    Lochmueller, Hanns
    Sejersen, Thomas
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (04) : 501 - 520
  • [29] Familial predisposition to Psychotic illness in Huntington's disease
    Chakravarty, Rahul Kumar
    Shah, Ruchita
    INDIAN JOURNAL OF PSYCHIATRY, 2018, 60 (05) : 154 - 154
  • [30] The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis
    Pringsheim, Tamara
    Wiltshire, Katie
    Day, Lundy
    Dykeman, Jonathan
    Steeves, Thomas
    Jette, Nathalie
    MOVEMENT DISORDERS, 2012, 27 (09) : 1083 - 1091